Editors' Note: The Index Vein Pointing to the Origin of the Migraine Aura Symptom: A Case Series
Abstract
Dr. Slavova et al. presented a case series of 6 patients with acute migraine aura who had a prominent draining sulcal vein on emergency MRI susceptibility-weighted imaging (SWI) initially performed for suspected stroke. The vein pointed toward the cortical area that correlated with the clinical presentation. In response, Drs. Bugnicourt and Godefroy raise several concerns regarding the “index vein” finding reported by the authors, including the fact that only 1 patient had demonstrated reversibility of the SWI abnormality, adding to 3 previous case reports that demonstrated reversible venous dilatation in migraine aura; the inclusion of only 6 patients over 7 years, raising questions about the frequency of this finding; the absence of 3D time-of-flight magnetic resonance angiography (MRA) findings in the results; and uncertainty about the underlying mechanism of this finding. Responding to these comments, the authors agree that there are enduring questions regarding the mechanism, reversibility, and potentially low prevalence of the index vein finding, but note that their intention was to introduce this phenomenon and propose a definition that could then be used in future studies to evaluate its diagnostic accuracy for migraine aura. They report that time-of-flight MRA was normal in all reported patients. In summary, the appearance of a prominent vein potentially associated with a culprit cortical area in patients with migraine aura is a phenomenon that requires validation…
How strong is the evidence?
Evidence Hub reads this as a case series, done in people. Its evidence level is 5 of 5 (Very low · case / narrative / animal / in vitro / in silico). Case reports, narrative reviews, and animal, cell or computer-model studies give the weakest evidence for human health. Reported size: 6 participants or records.
Read the paper
Related studies
- Calcium Ions in the Physiology and Pathology of the Central Nervous System
- AI-powered in silico twins: redefining precision medicine through simulation, personalization, and predictive healthcare
- In silico functional, structural and pathogenicity analysis of missense single nucleotide polymorphisms in human MCM6 gene
- In Silico drug repurposing pipeline using deep learning and structure based approaches in epilepsy
- Targeting serotonin receptors with phytochemicals – an in-silico study
- In silico exploration of anti-prostate cancer compounds from differential expressed genes
Go deeper in Evidence Hub
Evidence Hub adds a study data sheet (design, sample size, evidence level, key numbers), an AI summary and a chat grounded in the paper's text.